The Hippo Signaling Pathway in Pancreatic β-Cells: Functions and Regulations

被引:45
作者
Ardestani, Amin [1 ]
Maedler, Kathrin [1 ]
机构
[1] Univ Bremen, Ctr Biomol Interact Bremen, D-28359 Bremen, Germany
基金
欧洲研究理事会;
关键词
ORGAN SIZE CONTROL; CASPASE-MEDIATED ACTIVATION; KINASE; MST1; PROTEIN-KINASE; TISSUE-GROWTH; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; EFFECTOR YAP; INTESTINAL REGENERATION; PROTEOLYTIC ACTIVATION;
D O I
10.1210/er.2017-00167
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hippo signaling is an evolutionarily conserved pathway that critically regulates development and homeostasis of various tissues in response to a wide range of extracellular and intracellular signals. As an emerging important player in many diseases, the Hippo pathway is also involved in the pathophysiology of diabetes on the level of the pancreatic islets. Multiple lines of evidence uncover the importance of Hippo signaling in pancreas development as well as in the regulation of beta-cell survival, proliferation, and regeneration. Hippo therefore represents a potential target for therapeutic agents designed to improve beta-cell function and survival in diabetes. In this review, we summarize recent data on the regulation of the Hippo signaling pathway in the pancreas/in pancreatic islets, its functions on beta-cell homeostasis in physiology and pathophysiology, and its contribution toward diabetes progression. The current knowledge related to general mechanisms of action and the possibility of exploiting the Hippo pathway for therapeutic approaches to block beta-cell failure in diabetes is highlighted.
引用
收藏
页码:21 / 35
页数:15
相关论文
共 169 条
[1]   Natural history of β-cell adaptation and failure in type 2 diabetes [J].
Alejandro, Emilyn U. ;
Gregg, Brigid ;
Blandino-Rosano, Manuel ;
Cras-Meneur, Corentin ;
Bernal-Mizrachi, Ernesto .
MOLECULAR ASPECTS OF MEDICINE, 2015, 42 :19-41
[2]   Toward the Development of a Potent and Selective Organoruthenium Mammalian Sterile 20 Kinase Inhibitor [J].
Anand, Ruchi ;
Maksimoska, Jasna ;
Pagano, Nicholas ;
Wong, Eric Y. ;
Gimotty, Phyllis A. ;
Diamond, Scott L. ;
Meggers, Eric ;
Marmorstein, Ronen .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (06) :1602-1611
[3]   Gene Regulatory Networks Governing Pancreas Development [J].
Arda, H. Efsun ;
Benitez, Cecil M. ;
Kim, Seung K. .
DEVELOPMENTAL CELL, 2013, 25 (01) :5-13
[4]  
Ardestani A, 2017, DIABETES A, VA2169, P1
[5]   MST1: a promising therapeutic target to restore functional beta cell mass in diabetes [J].
Ardestani, Amin ;
Maedler, Kathrin .
DIABETOLOGIA, 2016, 59 (09) :1843-1849
[6]   MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes [J].
Ardestani, Amin ;
Paroni, Federico ;
Azizi, Zahra ;
Kaur, Supreet ;
Khobragade, Vrushali ;
Yuan, Ting ;
Frogne, Thomas ;
Tao, Wufan ;
Oberholzer, Jose ;
Pattou, Francois ;
Conte, Julie Kerr ;
Maedler, Kathrin .
NATURE MEDICINE, 2014, 20 (04) :385-+
[7]   Glucose Effects on Beta-Cell Growth and Survival Require Activation of Insulin Receptors and Insulin Receptor Substrate 2 [J].
Assmann, Anke ;
Ueki, Kohjiro ;
Winnay, Jonathon N. ;
Kadowaki, Takahashi ;
Kulkarni, Rohit N. .
MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (11) :3219-3228
[8]   Cellular and molecular mechanisms coordinating pancreas development [J].
Bastidas-Ponce, Aimee ;
Scheibner, Katharina ;
Lickert, Heiko ;
Bakhti, Mostafa .
DEVELOPMENT, 2017, 144 (16) :2873-2888
[9]   The transcriptional landscape of mouse beta cells compared to human beta cells reveals notable species differences in long non-coding RNA and protein-coding gene expression [J].
Benner, Christopher ;
van der Meulen, Talitha ;
Caceres, Elena ;
Tigyi, Kristof ;
Donaldson, Cynthia J. ;
Huising, Mark O. .
BMC GENOMICS, 2014, 15
[10]   Islet β cell expression of constitutively active Akt1/PKBα induces striking hypertrophy, hyperplasia, and hyperinsulinemia [J].
Bernal-Mizrachi, E ;
Wen, W ;
Stahlhut, S ;
Welling, CM ;
Permutt, MA .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (11) :1631-1638